How does mutant huntingtin affect Huntington Disease?
Searched over 200M research papers
Research Analysis by Consensus
Consensus Meter
Impact of Mutant Huntingtin on Huntington's Disease
Introduction to Huntington's Disease and Mutant Huntingtin
Huntington's disease (HD) is a neurodegenerative disorder caused by a CAG trinucleotide repeat expansion in the HTT gene, leading to the production of a mutant huntingtin protein (mHTT) . This mutation results in a gain-of-function that is toxic to neurons, particularly in the striatum and cortex, leading to the characteristic motor, cognitive, and psychiatric symptoms of HD .
Mechanisms of Mutant Huntingtin Toxicity
Disruption of Cellular Functions
Mutant huntingtin disrupts several cellular processes, including transcription, proteostasis, and mitochondrial function. It interferes with normal gene expression, leading to transcriptional dysregulation observed in both human HD brains and various mouse models. Additionally, mHTT impairs mitochondrial dynamics, causing mitochondrial fragmentation, defective axonal transport, and synaptic degeneration . These disruptions contribute to neuronal dysfunction and death, exacerbating the progression of HD .
Impaired Immune Cell Function
Mutant huntingtin also affects immune cell function. Studies have shown that mHTT impairs the migration of microglia and other immune cells, which may contribute to the neuroinflammatory environment observed in HD. This impaired migration is linked to defective actin remodeling, further highlighting the widespread impact of mHTT on cellular functions.
Therapeutic Strategies Targeting Mutant Huntingtin
Antisense Oligonucleotides (ASOs)
One promising therapeutic approach involves the use of antisense oligonucleotides (ASOs) to reduce the levels of mHTT. Clinical trials have demonstrated that ASOs can effectively lower mHTT concentrations in the cerebrospinal fluid (CSF) of HD patients, leading to a dose-dependent reduction in mHTT levels without serious adverse events . This reduction in mHTT is associated with decreased HD pathology and improved motor, cognitive, and behavioral phenotypes in preclinical models .
Other Huntingtin-Lowering Strategies
Other strategies to lower huntingtin levels include the use of miRNA and autophagy-based approaches. These methods aim to either reduce the production of mHTT or enhance its clearance from cells. While these approaches are still in the experimental stages, they hold promise for future therapeutic development.
Conclusion
Mutant huntingtin plays a central role in the pathogenesis of Huntington's disease by disrupting various cellular processes and impairing immune cell function. Therapeutic strategies that target the reduction of mHTT levels, such as antisense oligonucleotides, show significant potential in mitigating the effects of HD. Continued research into these and other huntingtin-lowering approaches is crucial for developing effective treatments for this devastating condition.
Sources and full results
Most relevant research papers on this topic
Targeting Huntingtin Expression in Patients with Huntington's Disease.
Huntingtin-Lowering Therapies for Huntington Disease: A Review of the Evidence of Potential Benefits and Risks.
Huntingtin-lowering strategies for Huntington’s disease
Molecular mechanisms and potential therapeutical targets in Huntington's disease.
Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage.
Mutant huntingtin impairs immune cell migration in Huntington disease.
Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage.
Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin Synthesis
Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease.
Huntington's disease: a clinical review
Try another search
wind turbine
What are the policies and regulations governing environmental protection?
Does Serum carboxymethyl lysine cause atherosclerosis?
How much Vitamin D (D2: Ergocalciferol, and D3: Cholecalciferol) should I take daily?
What is the role of robotics in elderly care and assistance?
How can blockchain improve security?